Session 5: Viral Vectors - Innovation in AAV: Building the next generation of safe, scalable and affordable vector platforms

Name: Session 5: Viral Vectors - Innovation in AAV: Building the next generation of safe, scalable and affordable vector platforms
Start: 2027-01-20T11:00
End: 2027-01-20T12:00
Location: San Diego Convention Center

Advanced Therapies Week 2027 · 20 January 2027 · 11:00–12:00 · Theatre 3

Session 5: Viral Vectors - Innovation in AAV: Building the next generation of safe, scalable and affordable vector platforms was a session at Advanced Therapies Week 2027 on 20 January 2027 in San Diego, with 3 speakers on record.

Speakers

Mark Kay — Speaker Dennis Farrey Family Professor, Departments of Pediatrics and Genetics; Head, Division of Human Gene Therapy, Stanford University
Romuald Corbau — Speaker CSO, Capsida Biotherapeutics
Katy Barglow — Speaker CTO, 4D Molecular Therapeutics